Expertise Partner
Luxna Biotech
Luxna Biotech is a preclinical stage antisense drug development company. Our technologies are novel modified nucleoside which is bridged structure in the sugar skeleton (Xeno Nucleic Acid, XNA) and 5’-modified DNA (5’-CP ) invented by Osaka University. Our antisense (ASO) drug discovery platform “LuxiAP™” allow us to select multiple highly potent ASOs (Gapmer and Splicing switch oligonucleotide) and optimize to the safer and more potent ASOs. With our novel XNAs and 5’-CP technology our ultimate goal is delivering effective ASO therapies for patients struggling with neurological diseases and disorders.
Exhibition Partner
ChemGenes
ChemGenes, an ISO 9001 certified company established in 1981, is the industry leader in manufacturing oligonucleotide synthesis reagents and has consistently provided the highest quality phosphoramidites and solid supports in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. In addition, ChemGenes is expanding its custom oligonucleotide synthesis department specializing in the manufacture of ASOs, siRNA, gRNA, gapmers, aptamers, DNA based probes, and superior quality beads for Single Cell mRNA sequencing applications using Drop-Seq, Slide-seq, and Seq-Well methods. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Creative Biolabs
Creative Biolabs is dedicated to serving life science researchers worldwide through our global network. As the very first company to offer a broad range of leading technologies and products in neuroscience, we provide high-quality antibodies, proteins, cell lines, culture tools, and modulators. Our customized services cover all aspects of neuroscience to meet your specific needs. Leveraging integrated global resources, we deliver cutting-edge platforms that accelerate neurology research and advance science for a better tomorrow.
Sierra BioSystems
Sierra BioSystems is transforming the biotechnology landscape by making genetic research tools accessible worldwide. Founded by a team of innovative engineers, we are committed to tackling the challenges of high synthetic DNA costs.
Our flagship product, the Shasta synthesizer, embodies our mission to deliver high-quality, high-throughput synthesis at a fraction of the cost. In partnership with K&A Laboratories, we elevate our oligonucleotide synthesis portfolio by combining our cutting-edge technology with K&A’s renowned closed column synthesizers, ensuring unmatched versatility and reliability.
Whether synthesizing a few strands or complex genes, our bench-top synthesizers meet diverse needs. Join us in revolutionizing genetic research—at Sierra BioSystems, we empower researchers to unlock their potential and drive groundbreaking discoveries.
SynOligo
Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.
Transpharmation
Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience expertise, utilizing behavioral and molecular assays to help clients benchmark compounds. With extensive experience in antibiotic treatments and diet manipulations, we study their effects on the microbiome. Committed to on-time data delivery and providing flexible, customized solutions, we support clients in optimizing preclinical assets for the development of life-changing medicines.
